These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 3048049)
1. Noradrenergic and serotonergic receptor system function in panic disorder and depression. Heninger GR; Charney DS; Price LH Acta Psychiatr Scand Suppl; 1988; 341():138-50. PubMed ID: 3048049 [TBL] [Abstract][Full Text] [Related]
2. Comorbidity of panic disorder and major depressive disorder: effects on platelet alpha 2 adrenergic receptors. Grunhaus LJ; Cameron O; Pande AC; Haskett RF; Hollingsworth PJ; Smith CB Acta Psychiatr Scand; 1990 Mar; 81(3):216-9. PubMed ID: 2160772 [TBL] [Abstract][Full Text] [Related]
3. Behavioral indications for serotonin receptor hypersensitivity in panic disorder. Kahn RS; Wetzler S; van Praag HM; Asnis GM; Strauman T Psychiatry Res; 1988 Jul; 25(1):101-4. PubMed ID: 3217461 [TBL] [Abstract][Full Text] [Related]
4. Adrenergic status in anxiety disorders: platelet alpha 2-adrenergic receptor binding, blood pressure, pulse, and plasma catecholamines in panic and generalized anxiety disorder patients and in normal subjects. Cameron OG; Smith CB; Lee MA; Hollingsworth PJ; Hill EM; Curtis GC Biol Psychiatry; 1990 Jul; 28(1):3-20. PubMed ID: 2165422 [TBL] [Abstract][Full Text] [Related]
5. Cortisol response to clonidine in panic disorder: comparison with depressed patients and normal controls. Stein MB; Uhde TW Biol Psychiatry; 1988 Jul; 24(3):322-30. PubMed ID: 2840978 [TBL] [Abstract][Full Text] [Related]
6. Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder. Charney DS; Heninger GR; Breier A Arch Gen Psychiatry; 1984 Aug; 41(8):751-63. PubMed ID: 6742977 [TBL] [Abstract][Full Text] [Related]
8. Abnormal regulation of noradrenergic function in panic disorders. Effects of clonidine in healthy subjects and patients with agoraphobia and panic disorder. Charney DS; Heninger GR Arch Gen Psychiatry; 1986 Nov; 43(11):1042-54. PubMed ID: 3021083 [TBL] [Abstract][Full Text] [Related]
9. Blunted growth hormone response to clonidine in patients with generalized anxiety disorder. Abelson JL; Glitz D; Cameron OG; Lee MA; Bronzo M; Curtis GC Arch Gen Psychiatry; 1991 Feb; 48(2):157-62. PubMed ID: 1989571 [TBL] [Abstract][Full Text] [Related]
14. Noradrenergic neuronal dysregulation in panic disorder: the effects of intravenous yohimbine and clonidine in panic disorder patients. Charney DS; Woods SW; Krystal JH; Nagy LM; Heninger GR Acta Psychiatr Scand; 1992 Oct; 86(4):273-82. PubMed ID: 1333719 [TBL] [Abstract][Full Text] [Related]
15. Effect of a serotonin and noradrenaline uptake inhibitor in panic disorder; a double-blind comparative study with fluvoxamine and maprotiline. Den Boer JA; Westenberg HG Int Clin Psychopharmacol; 1988 Jan; 3(1):59-74. PubMed ID: 2833543 [TBL] [Abstract][Full Text] [Related]
16. Neuroendocrine evidence for serotonin receptor hypersensitivity in panic disorder. Kahn RS; Asnis GM; Wetzler S; van Praag HM Psychopharmacology (Berl); 1988; 96(3):360-4. PubMed ID: 2906153 [TBL] [Abstract][Full Text] [Related]
17. Biological alterations in the primary affective disorders and other tricyclic-responsive disorders. Siever LJ; Uhde TW; Insel TR; Kaye WH; Jimerson DC; Lake CR; Kafka M; Targum S; Murphy DL Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(1):15-24. PubMed ID: 2986198 [TBL] [Abstract][Full Text] [Related]